Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

The Edit vs WeightCare

By GLP-1 ScorecardUpdated

The EditFactor scores not reassessed.
Site position #117

Higher score

WeightCareFactor scores not reassessed.
Site position #498

Lower score

Score comparison

The Edit has the higher recorded score — 70.4/100 to 52.2/100.

The Edit grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Edit holds one price at every dose, charges nothing to start, refunds in full if you are not approved, and then says none of its published policies actually govern.

Before you choose

Before comparing the headline prices, the The Edit review and the WeightCare review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, The Edit vs WeightRx and Tonik Wellness vs WeightCare compare each of them with another graded program, and the list of alternatives to The Edit ranks the programs closest to The Edit on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the SkinnyRx review covers one graded close to these two, at 60.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueThe Edit +15
50
35
Dose & formulationThe Edit +10
72
62
Clinical oversightThe Edit +25
80
55
Labs & monitoringThe Edit +8
62
54
FulfillmentThe Edit +23
95
72
Contract termsThe Edit +44
85
41
The Edit · top barWeightCare · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricThe EditWeightCare
WeighScore70.4/10052.2/100
GradeCC
Site position#117#498
Semaglutide$259/mo (standing rate, flat at every dose; $200 covers the first month only)$249/mo on a 3-month plan ($139/mo on a 12-month plan)
Tirzepatide$349/mo (standing rate, flat at every dose; $300 covers the first month only)$299/mo on a 3-month starter plan ($216/mo on a 12-month plan, any dose)
CoverageAll 50 states (claimed; hedged in the same paragraph, no list published)Coverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
The Edit

Site position #117 · C

Factor scores not reassessed.

Strengths

  • The price is flat at every dose with no titration ladder, so the figure a reader sees is the figure at maintenance
  • Nothing is charged and no card is taken to begin, and a full refund applies if a clinician does not approve treatment
  • Names its medical director with an NPI number and the medical practice behind him, and names a dispensing pharmacy
  • Prescription medication, injection supplies, the clinician visit and ongoing care are itemized as included, with no membership fee
  • A separate hormone menu is priced beside the GLP-1 lines

What to consider

  • $200 and $300 are first-order promotional prices printed larger than the struck standing rates of $259 and $349, and the promotion carries no end date and no code
  • The published cancellation and refund policies say the Membership Agreement controls where they differ, and that nothing on the public site is binding — so the terms a reader can read are not the terms that apply
  • Two-day shipping is transit time only; the site's own shipping policy states an average of 4 to 12 business days from prescription
  • “Available in all 50 U.S. states” is hedged in the same paragraph and no state list is published anywhere
  • The three- and six-month figures are one charge, not a monthly rate, and the per-month numbers beside them are arithmetic rather than billing
  • The named pharmacy is described as one member of a plural pharmacy network whose other members are not named
  • No compounding class is stated, and whether a separate visit fee is ever charged is not answered
WeightCare

Site position #498 · C

Factor scores not reassessed.

FDAWarning letter issued to Weightless Medical LLC dba WeightCare in February 2026. See the FDA warning-letter database.

Strengths

  • PCAB-accredited pharmacy partners — strongest pharmacy quality signal
  • Quality testing: potency and sterility per USP 797 standards
  • 85,000+ members since 2022 — established patient base
  • Multiple program tiers for semaglutide
  • Health coaching, dietitians, fitness trainers included

What to consider

  • No LegitScript certification on the site itself
  • State availability not explicitly listed
  • Compounded only — no brand-name options
  • The lowest rates ($139 semaglutide, $216 tirzepatide) require a 12-month plan; 3-month plans are $249 and $299
  • FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard